The guidelines take aim at strokes, not just heart attacks. They’re personalized for men and women, and blacks and whites. They estimate a person’s risk in a novel way and change the goal of treating high cholesterol.
A new formula includes age, sex, race, blood pressure, cholesterol, diabetes and smoking. People ages 40 to 79 should get an estimate every four to six years. If risk is still unclear, family history or three other tests can be considered.
The guidelines don’t change the definition of high cholesterol, but they say doctors should no longer aim for a specific number with whatever drugs can get a patient there. The new advice stresses statins such as Lipitor and Zocor; most are generic and cost as little as a dime a day.
Who needs treatment?
Four groups are targeted:
•People who already have heart disease (clogged arteries)
•Those whose LDL, or “bad cholesterol,” is 190 or higher, usually because of genetic risk
•People ages 40 to 75 with Type 2 diabetes
•People ages 40 to 75 who have an estimated 10-year risk of heart attack or stroke of 7.5 percent or higher, based on the new formula. (This means that for every 100 people with a similar risk profile, seven to eight would have a heart attack or a stroke within 10 years.)
The role of lifestyle
The new guidelines also recommend 40 minutes of moderate to vigorous exercise three to four times a week. They call for a “dietary pattern” that is focused on vegetables, fruits and whole grains, and includes low-fat dairy products, poultry, fish, beans, and healthy oils and nuts. Limit sweets, sweet drinks, red meat, saturated fat and salt.
To fight obesity, doctors should develop individualized weight-loss plans including a moderately reduced-calorie diet, exercise and behavior strategies. The best plans offer two to three in-person meetings a month for at least six months. Web or phone-based programs are a less ideal option.
— Associated Press
The nation’s first new guidelines in a decade for preventing heart attacks and strokes call for twice as many Americans — one-third of all adults — to consider taking cholesterol-lowering statin drugs.
The guidelines, issued Tuesday by the American Heart Association and American College of Cardiology, are a big change. They use a new formula for estimating someone’s risk that includes many factors besides cholesterol, the main focus now. The guidelines take aim at strokes, not just heart attacks. And they set a lower threshold for using medicines to reduce risk.
The definition of high cholesterol isn’t changing, but the treatment goal is. Instead of aiming for a specific number, using whatever drugs get a patient there, the advice stresses statins such as Lipitor and Zocor and identifies four groups of people they help the most.
“The emphasis is to try to treat more appropriately,” said Dr. Neil Stone, the Northwestern University doctor who headed the cholesterol guideline panel. “We’re going to give statins to those who are the most likely to benefit.”
Doctors say the new approach will limit how many people with low heart risks are put on statins simply because of a cholesterol number. Yet under the new advice, 33 million Americans — 44 percent of men and 22 percent of women — would meet the threshold to consider taking a statin. Only 15 percent of adults do now.
Some doctors not involved in writing the guidance worry that it will be tough to understand.
“It will be controversial, there’s no question about it. For as long as I remember, we’ve told physicians and patients we should treat their cholesterol to certain goal levels,” said the Cleveland Clinic’s Dr. Steven Nissen. “There is concern that there will be a lot of confusion about what to do.”
The government’s National Heart, Lung and Blood Institute appointed expert panels to write the new guidelines in 2008, but in June said it would leave drafting them to the Heart Association and College of Cardiology.
Roughly half the cholesterol panel members have financial ties to makers of heart drugs, but panel leaders said no one with industry connections could vote on the recommendations.
“It is practically impossible to find a large group of outside experts in the field who have no relationships to industry,” said Dr. George Mensah of the heart institute. He called the guidelines “a very important step forward” based on solid evidence, and said the public should trust them.
Heart disease is the leading cause of death worldwide. High cholesterol leads to hardened arteries that can cause a heart attack or stroke. Most cholesterol is made by the liver, so diet changes have a limited effect on it.
Millions of Americans take statins, which reduce cholesterol dramatically and have other effects that more broadly lower the chances of heart trouble.
The patents on Lipitor, Zocor and other statins have expired, and they are widely available in generic versions for as little as a dime a day. One that is still under patent protection is AstraZeneca’s Crestor, which had sales of $8.3 billion in 2012.
Despite a small increased risk of muscle problems and accelerating diabetes in patients already at risk for it, statins are “remarkably safe drugs” whose benefits outweigh their risks, said Dr. Donald Lloyd-Jones, preventive-medicine chief at Northwestern.
“I don’t like the concept of ‘good foods’ and ‘bad foods,’” said Dr. Robert Eckel, a University of Colorado cardiologist who worked on the guidelines. “We really want to emphasize dietary patterns.”